Company: RGNX
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0000950170-25-038770
Chunk: 288

Company: REGENXBIO Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1B
Chunk 288
---
 to License Agreement dated March 6, 2009 between the Registrant and The Trustees of the University of Pennsylvania
     
    S-1
     
    10.10
     
    8/17/15

    10.16†
     
    Second Amendment to License Agreement effective September 9, 2014 between the Registrant and The Trustees of the University of Pennsylvania
     
    S-1/A
     
    10.11
     
    9/15/15

    10.17†
     
    Third Amendment to License Agreement effective April 29, 2016 between the Registrant and The Trustees of the University of Pennsylvania
     
    10-Q/A
     
    10.36
     
    12/23/16

    10.18†
     
    Fourth Amendment to License Agreement effective April 4, 2019 between the Registrant and The Trustees of the University of Pennsylvania
     
    10-Q
     
    10.2
     
    5/7/19

128

    Incorporated by Reference

    ExhibitNumber
     
    Description
     
    Form
     
    ExhibitNumber
     
    Filing Date
     
    Filed orFurnishedHerewith

    10.19†
     
    Fifth Amendment to License Agreement effective September 11, 2020 between the Registrant and The Trustees of the University of Pennsylvania
     
    10-Q
     
    10.2
     
    11/4/20

    10.20†
     
    Letter Agreement dated March 21, 2022 between the Company and the Trustees of the University of Pennsylvania
     
    10-Q
     
    10.1
     
    5/4/22

    10.21†
     
    License Agreement dated March 6, 2009 between the Registrant and SmithKline Beecham Corporation d/b/a GlaxoSmithKline
     
    S-1/A
     
    10.12
     
    9/15/15

    10.22
     
    Amendment to License Agreement dated April 15, 2009 between the Registrant and SmithKline Beecham Corporation d/b/a GlaxoSmithKline
     
    S-